Loading…
DeltaNp63 expression in pancreas and pancreatic neoplasia
DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, th...
Saved in:
Published in: | Modern pathology 2005-09, Vol.18 (9), p.1193-1198 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483 |
---|---|
cites | cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483 |
container_end_page | 1198 |
container_issue | 9 |
container_start_page | 1193 |
container_title | Modern pathology |
container_volume | 18 |
creator | Basturk, Olca Khanani, Fayyaz Sarkar, Fazlul Levi, Edi Cheng, Jeanette D Adsay, N Volkan |
description | DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63 |
doi_str_mv | 10.1038/modpathol.3800401 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68500527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0893395222045574</els_id><sourcerecordid>969913611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</originalsourceid><addsrcrecordid>eNp9kEFP3DAUhK0K1N3S_gAOoKiH3gLPdux1xKmiLSAhuLRn663zFoyyTrATVP49XmVhJQ6cLGtmPo-HsUMOJxykOV13TY_DfdeeSANQAf_E5lxJKEEYtcfmYGpZylqJGfuS0gMAr5QRn9mMq3qhDa_mrP5F7YA3vZYF_e8jpeS7UPhQ9BhcJEwFhub1MnhXBOr6FpPHr2x_hW2ib9vzgP378_vv-WV5fXtxdf7zunSV0UNZSyeWsEKsuaEqd1ELg3rpwCGXGmrSvEKtHDpQTlSaO7NYEee1UwhNZeQB-zFx-9g9jpQGu_bJUdtirjImq40CUGKRjd_fGR-6MYbczQrB85dBbWh8MrnYpRRpZfvo1xifLQe7GdW-jWq3o-bM8RY8LtfU7BLbFbNBTIaUpXBHcffyR9SjKRRwGCO9UXf62aRTHvfJZ2hynoKjxkdyg206_wH9BTzRorU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221159058</pqid></control><display><type>article</type><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><source>Nature</source><creator>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</creator><creatorcontrib>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</creatorcontrib><description>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/modpathol.3800401</identifier><identifier>PMID: 15976814</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Biomarkers, Tumor - analysis ; Cancer ; Carcinoma in Situ - metabolism ; Carcinoma in Situ - pathology ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Cell cycle ; Cyst ; DNA-Binding Proteins ; Gene amplification ; Genes, Tumor Suppressor ; Humans ; Immunohistochemistry ; invasive ductal adenocarcinoma ; Laboratory Medicine ; Medicine ; Medicine & Public Health ; metaplasia ; original-article ; p63 ; Pancreas ; Pancreatic Ducts - metabolism ; Pancreatic Ducts - pathology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; PanIN ; Pathology ; Phosphoproteins - biosynthesis ; Prostate ; Trans-Activators - biosynthesis ; Transcription Factors ; Tumor Suppressor Proteins ; Tumors</subject><ispartof>Modern pathology, 2005-09, Vol.18 (9), p.1193-1198</ispartof><rights>2005 United States & Canadian Academy of Pathology</rights><rights>United States and Canadian Academy of Pathology, Inc. 2005</rights><rights>Copyright Nature Publishing Group Sep 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</citedby><cites>FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2727,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15976814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Basturk, Olca</creatorcontrib><creatorcontrib>Khanani, Fayyaz</creatorcontrib><creatorcontrib>Sarkar, Fazlul</creatorcontrib><creatorcontrib>Levi, Edi</creatorcontrib><creatorcontrib>Cheng, Jeanette D</creatorcontrib><creatorcontrib>Adsay, N Volkan</creatorcontrib><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Cancer</subject><subject>Carcinoma in Situ - metabolism</subject><subject>Carcinoma in Situ - pathology</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Cell cycle</subject><subject>Cyst</subject><subject>DNA-Binding Proteins</subject><subject>Gene amplification</subject><subject>Genes, Tumor Suppressor</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>invasive ductal adenocarcinoma</subject><subject>Laboratory Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>metaplasia</subject><subject>original-article</subject><subject>p63</subject><subject>Pancreas</subject><subject>Pancreatic Ducts - metabolism</subject><subject>Pancreatic Ducts - pathology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>PanIN</subject><subject>Pathology</subject><subject>Phosphoproteins - biosynthesis</subject><subject>Prostate</subject><subject>Trans-Activators - biosynthesis</subject><subject>Transcription Factors</subject><subject>Tumor Suppressor Proteins</subject><subject>Tumors</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kEFP3DAUhK0K1N3S_gAOoKiH3gLPdux1xKmiLSAhuLRn663zFoyyTrATVP49XmVhJQ6cLGtmPo-HsUMOJxykOV13TY_DfdeeSANQAf_E5lxJKEEYtcfmYGpZylqJGfuS0gMAr5QRn9mMq3qhDa_mrP5F7YA3vZYF_e8jpeS7UPhQ9BhcJEwFhub1MnhXBOr6FpPHr2x_hW2ib9vzgP378_vv-WV5fXtxdf7zunSV0UNZSyeWsEKsuaEqd1ELg3rpwCGXGmrSvEKtHDpQTlSaO7NYEee1UwhNZeQB-zFx-9g9jpQGu_bJUdtirjImq40CUGKRjd_fGR-6MYbczQrB85dBbWh8MrnYpRRpZfvo1xifLQe7GdW-jWq3o-bM8RY8LtfU7BLbFbNBTIaUpXBHcffyR9SjKRRwGCO9UXf62aRTHvfJZ2hynoKjxkdyg206_wH9BTzRorU</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Basturk, Olca</creator><creator>Khanani, Fayyaz</creator><creator>Sarkar, Fazlul</creator><creator>Levi, Edi</creator><creator>Cheng, Jeanette D</creator><creator>Adsay, N Volkan</creator><general>Elsevier Inc</general><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>DeltaNp63 expression in pancreas and pancreatic neoplasia</title><author>Basturk, Olca ; Khanani, Fayyaz ; Sarkar, Fazlul ; Levi, Edi ; Cheng, Jeanette D ; Adsay, N Volkan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Cancer</topic><topic>Carcinoma in Situ - metabolism</topic><topic>Carcinoma in Situ - pathology</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Cell cycle</topic><topic>Cyst</topic><topic>DNA-Binding Proteins</topic><topic>Gene amplification</topic><topic>Genes, Tumor Suppressor</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>invasive ductal adenocarcinoma</topic><topic>Laboratory Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>metaplasia</topic><topic>original-article</topic><topic>p63</topic><topic>Pancreas</topic><topic>Pancreatic Ducts - metabolism</topic><topic>Pancreatic Ducts - pathology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>PanIN</topic><topic>Pathology</topic><topic>Phosphoproteins - biosynthesis</topic><topic>Prostate</topic><topic>Trans-Activators - biosynthesis</topic><topic>Transcription Factors</topic><topic>Tumor Suppressor Proteins</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basturk, Olca</creatorcontrib><creatorcontrib>Khanani, Fayyaz</creatorcontrib><creatorcontrib>Sarkar, Fazlul</creatorcontrib><creatorcontrib>Levi, Edi</creatorcontrib><creatorcontrib>Cheng, Jeanette D</creatorcontrib><creatorcontrib>Adsay, N Volkan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basturk, Olca</au><au>Khanani, Fayyaz</au><au>Sarkar, Fazlul</au><au>Levi, Edi</au><au>Cheng, Jeanette D</au><au>Adsay, N Volkan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DeltaNp63 expression in pancreas and pancreatic neoplasia</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>18</volume><issue>9</issue><spage>1193</spage><epage>1198</epage><pages>1193-1198</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>DeltaNp63 (DNp63) has become widely used, in particular, for distinguishing invasive carcinomas from noninvasive ducts by highlighting the myoepithelial or basal cells in the breast and prostate, respectively. It is not known whether this marker may have any application in another exocrine organ, the pancreas. As the ductal and intraductal proliferations of this organ become better characterized, the need for markers to distinguish among these processes increases. We investigated immunohistochemical expression of DNP63 in 105 cases. A total of 25 cases were non-neoplastic pancreata, 25 were pancreatic intraepithelial neoplasia (PanIN) of various grades, and 50 were examples of pancreatic ductal adenocarcinoma. Sections of non-neoplastic pancreata included various types of non-neoplastic processes such as squamous/transitional metaplasia (five cases), which can be mistaken for high-grade PanINs, as well as various degrees of reactive ductal atypia and incidental microcysts with attenuated lining (five cases). No DNp63 expression was noted in normal pancreatic ducts. On the other hand, all five foci of squamous/transitional metaplasia were strongly and uniformly positive for this marker. DNp63 labeling was also noted in those incidental microcysts lined by attenuated cells, seen amidst normal pancreatic lobules. All PanINs were negative. Among invasive carcinomas, DNp63 expression was detected only in areas of squamous differentiation and was completely absent in ordinary ductal areas. Based on this observation, five additional cases of adenosquamous/squamous carcinoma was retrieved and stained, and the squamous components of all of these were also positive. In conclusion, (I) DNp63 is a reliable marker of squamous differentiation in the pancreas. It is valuable in distinguishing squamous/transitional metaplasia from PanINs, a distinction of importance for both researchers and diagnosticians. Among invasive carcinomas, it seems to be entirely specific for areas of squamous differentiation. (II) Those incidental microcysts seen in acinar lobules and lined by attenuated cells are also positive for DNp63, which suggests that they may be metaplastic in nature, and that they do not represent neoplastic cells. (III) Unlike the ducts of other exocrine organs, breast and prostate, there are no DNp63-expressing cells in the normal pancreatic ducts, and therefore, this marker cannot be used in distinguishing invasive carcinomas from the non-invasive ducts. (IV) No p63-expressing ‘stem' cells are present in the pancreas.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><pmid>15976814</pmid><doi>10.1038/modpathol.3800401</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-3952 |
ispartof | Modern pathology, 2005-09, Vol.18 (9), p.1193-1198 |
issn | 0893-3952 1530-0285 |
language | eng |
recordid | cdi_proquest_miscellaneous_68500527 |
source | Nature |
subjects | Adenocarcinoma - metabolism Adenocarcinoma - pathology Biomarkers, Tumor - analysis Cancer Carcinoma in Situ - metabolism Carcinoma in Situ - pathology Carcinoma, Pancreatic Ductal - metabolism Carcinoma, Pancreatic Ductal - pathology Cell cycle Cyst DNA-Binding Proteins Gene amplification Genes, Tumor Suppressor Humans Immunohistochemistry invasive ductal adenocarcinoma Laboratory Medicine Medicine Medicine & Public Health metaplasia original-article p63 Pancreas Pancreatic Ducts - metabolism Pancreatic Ducts - pathology Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology PanIN Pathology Phosphoproteins - biosynthesis Prostate Trans-Activators - biosynthesis Transcription Factors Tumor Suppressor Proteins Tumors |
title | DeltaNp63 expression in pancreas and pancreatic neoplasia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A22%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DeltaNp63%20expression%20in%20pancreas%20and%20pancreatic%20neoplasia&rft.jtitle=Modern%20pathology&rft.au=Basturk,%20Olca&rft.date=2005-09-01&rft.volume=18&rft.issue=9&rft.spage=1193&rft.epage=1198&rft.pages=1193-1198&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1038/modpathol.3800401&rft_dat=%3Cproquest_cross%3E969913611%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c486t-93c2b0faa918e4952578a6bc0ca13609e614a65cac05c2461c87fe119c5a0d483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=221159058&rft_id=info:pmid/15976814&rfr_iscdi=true |